Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-036263
Filing Date
2024-02-14
Accepted
2024-02-14 16:19:04
Documents
1
Group Members
COLUMN GROUP III GP, LPCOLUMN GROUP III-A, LPCOLUMN GROUP OPPORTUNITY III GP, LPCOLUMN GROUP OPPORTUNITY III, LPTCG OPPORTUNITY III GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d726884dsc13da.htm SC 13D/A 111664
  Complete submission text file 0001193125-24-036263.txt   113514
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP III, LP (Filed by) CIK: 0001668159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92757 | Film No.: 24638633
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)